WSFS
STOK icon

Wilmington Savings Fund Society’s Stoke Therapeutics STOK Stock Holding History

Wilmington Savings Fund Society’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13K Hold
400
– – ﹤0.01% 1150
2025
Q4 		$12.7K Hold
400
– – ﹤0.01% 1146
2025
Q3 		$9.4K Hold
400
– – ﹤0.01% 1173
2025
Q2 		$4.54K Hold
400
– – ﹤0.01% 1775
2025
Q1 		$2.66K Hold
400
– – ﹤0.01% 1875
2024
Q4 		$4.41K Hold
400
– – ﹤0.01% 1828
2024
Q3 		$4.92K Buy
+400
New +$5.67K ﹤0.01% 1802

Other funds holding STOK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Wilmington Savings Fund Society's STOK Position: Q1 2026 in Review

Wilmington Savings Fund Society held its Stoke Therapeutics (STOK) position steady in Q1 2026 at 400 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #1150.

Wilmington Savings Fund Society first reported a position in STOK in Q3 2024 and has held it in 7 quarters since. 196 funds tracked by Wall St. Rank hold STOK as of Q1 2026.

  • Wilmington Savings Fund Society held 400 shares of Stoke Therapeutics worth $13K as of Q1 2026.
  • Wilmington Savings Fund Society left its Stoke Therapeutics share count unchanged in Q1 2026.
  • Stoke Therapeutics made up ﹤0.01% of Wilmington Savings Fund Society's portfolio in Q1 2026, its #1150 holding.
  • Wilmington Savings Fund Society first reported a position in Stoke Therapeutics in Q3 2024 and has held it in 7 quarters since.
  • 196 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q1 2026.

Based on Wilmington Savings Fund Society's 13F filing for Q1 2026, filed 30 Apr 2026.